Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Get a concise action plan for financial emergencies, including prioritizing essentials, securing funds, and communicating with creditors promptly.
16,835 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
In a volatile AI market, SoundHound AI posts a narrower loss for Q4 2025 and lifts 2025 revenue guidance, underscorin...
When a top executive at Yum China sells a large block of stock, investors pay attention. This article breaks down the...
Bybit reports a landmark security win, reclaiming $300 million for thousands of users through AI-powered fraud detect...
Berkshire Hathaway has resumed stock buybacks, purchasing $15 million of its own shares. CEO Greg Abel personally bou...
Retirees who depend solely on dividend-focused ETFs may be trimming potential income. Experts urge adding a deliberat...
TransUnion lowers VantageScore 4.0 pricing to 99 cents per score for mortgage lenders, with free access tied to FICO ...
Chevron announces a quarterly dividend of $1.78 per share, marking 39 years of uninterrupted growth. Q4 results show ...
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Adobe is navigating a fast-changing software landscape in 2026. This guide breaks down the 2026 earnings outlook, key...
A handful of savvy funds moved billions into Bitcoin last year. Here’s how that trend could impact your own investing...
More than 3,800 workers at a large Colorado meatpacking plant walked off Monday, marking the first major U.S. beef sl...